(2S,3S)-2-azaniumyl-3-methylbutanedioate CDK 2/12/10,15:28 10 9 0 0 0 0 0 0 0 0999 V2000 1.0717 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7862 -0.2062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7862 0.2062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 1.0313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 -1.0312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -1.0312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 7 2 0 0 0 0 2 1 1 0 0 0 0 2 10 1 1 0 0 0 1 3 1 0 0 0 0 4 8 2 0 0 0 0 4 5 1 0 0 0 0 6 2 1 0 0 0 0 4 6 1 0 0 0 0 6 9 1 1 0 0 0 M CHG 1 3 -1 M CHG 1 5 -1 M CHG 1 10 1 M END > CHEBI:58724 > threo-3-methyl-L-aspartate(1-) > Conjugate base of threo-3-methyl-L-aspartic acid. > 3 > (2S,3S)-3-methyl-L-aspartate > (2S,3S)-2-azaniumyl-3-methylbutanedioate > C5H8NO4 > 146.12130 > 146.04588 > -1 > C[C@@H]([C@H]([NH3+])C([O-])=O)C([O-])=O > InChI=1S/C5H9NO4/c1-2(4(7)8)3(6)5(9)10/h2-3H,6H2,1H3,(H,7,8)(H,9,10)/p-1/t2-,3-/m0/s1 > LXRUAYBIUSUULX-HRFVKAFMSA-M $$$$